Dr Azoulay has expertise in the design and analysis of pharmacoepidemiological studies using large patient databases. He has published extensively on the safety of antidiabetic drugs, including their effects on cancer incidence and cancer-related outcomes. To date, he has been published close to 100 papers, several of which were published in top-tier journals. His research programme is supported by provincial and national funding agencies.